2019 Annual Meeting of the American Association for the Study of Liver Diseases*

November 8-12, 2019; Boston, Massachusetts
Download slides or audio and review Capsule Summaries on practice-changing viral hepatitis and NAFLD/NASH data from Boston.
Ira M. Jacobson, MD
Nancy Reau, MD
Norah Terrault Headshot
Norah Terrault, MD, MPH
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD

Highlights

This downloadable slideset reviews new, clinically relevant data on viral hepatitis and NAFLD/NASH; topics include risk of HCC in patients with viral hepatitis, HBV and HCV treatment, organ transplant from donors with HCV infection, and novel treatments for NAFLD/NASH.

Ira M. Jacobson, MD Nancy Reau, MD Released: December 2, 2019

Listen to downloadable audio from a live Webinar reviewing the most clinically relevant new NAFLD/NASH data. Topics include global disease burden, treatments in development, and disease monitoring.

Zobair Younossi Headshot Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD Released: November 22, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on the most clinically relevant new viral hepatitis data presented at AASLD 2019, including updated information on HCV incidence and management and HBV management.

Norah Terrault Headshot Norah Terrault, MD, MPH Released: November 22, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue